Since estrogen deficiency leads to mitochondrial defects that provoke Alzheimer’s disease-associated pathological changes in a postmenopausal mouse model, the neuroprotective abilities of biochanin A were studied in an AD in vivo model with ovariectomized (OVX) APP/PS1 mice. Here, APP is linked to Alzheimer disease.